MPAA

Rated R for pervasive drug content and language

Certification

  • Australia:MA15+ (2008)
  • Iceland:16
  • Japan:R15+
  • New Zealand:R18
  • Singapore:R21
  • South Korea:18 (2016)
  • United Kingdom:18
  • United States:R (certificate #44239)